LEO Pharma A/S, a global leader in medical dermatology, today announced new long-term results from EFFISAYIL ® ON, an ongoing five-year open-label extension study of the pivotal ...
Claude extension flaw enabled silent prompt injection via XSS and weak allowlist, risking data theft and impersonation until ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results